Protalix BioTherapeutics, Inc. Common Stock

PLXAMEX • USD
2.55 USD
↘ 0.02 (0.78%)AT CLOSE (03:59 PM EDT)
2.55
↘ 0.01 (0.20%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
2.55
↘ 0.01 (0.20%)
🔴Market: CLOSED

Protalix BioTherapeutics, Inc. Common Stock (PLX) is currently trading at $2.55. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, exceptional Return on Equity (26.5%) and a bullish Golden Cross on the moving averages. Valuation metrics suggest PLX is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Oct 23, 2026.

Open?$2.54
High?$2.56
Low?$2.50
Prev. Close?$2.57
Volume?383.9K
Avg. Volume?851.7K
VWAP?$2.53
Rel. Volume?0.45x
Bid / Ask
Bid?$2.45 × 100
Ask?$2.56 × 300
Spread?$0.11
Midpoint?$2.51
Valuation & Ratios
Market Cap?205.5M
Shares Out?80.6M
Float?75.0M
Float %?93.1%
P/E Ratio?10.84
P/B Ratio?2.88
EPS?$0.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
Employees
226
Market Cap
205.5M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
1996-01-02
Address
2 UNIVERSITY PLAZA
HACKENSACK, NJ 07601
Phone: 201-696-9345
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
99
Momentum?
35
Short Sent.?
44
Piotroski F-Score?5/9Mixed
Altman Z-Score?5.26Safe
Confidence?53%Low
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?4.05%Low
Short Interest?3.0M
Days to Cover?4.3
Free Float75.0M
Avg Daily Volume709.1K
Settlement Date2026-09-30
Financial Health
Current Ratio?2.94Strong
Quick Ratio?1.91Adequate
Cash Ratio?0.87Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
94/100
P/E?
Peers
100
S&P
94
10.8CHEAP▾
P/B?
Peers
100
S&P
58
2.88CHEAP▾
P/S?
Peers
100
S&P
57
2.55CHEAP▾
P/FCF?
Peers
100
S&P
35
26.8FAIR▾
EV/EBITDA?
Peers
100
S&P
93
7.2CHEAP▾
EV/Sales?
Peers
100
S&P
72
2.21CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
76
26.5%STRONG▾
ROA?
Peers
50
S&P
91
17.2%STRONG▾
Cash Flow & Enterprise
FCF?$7.7M
Enterprise Value?$178.0M
Fundamentals ratios updated end of day